Unknown

Dataset Information

0

Breast Cancer Profiling Project, Drug Sensitivity 1: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics.

ABSTRACT:

SUBMITTER: Caitlin E. Mills, Marc Hafner 

PROVIDER: LDS-1519 | LINCS | 2018-03-30

REPOSITORIES: LINCS

Json Xml

Dataset's files

Source:
Action DRS
HMS_LINCS&file=LDS-1519.tar.gz Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown Breast Cancer Profiling Project, Drug Sensitivity 1: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values.
2018-03-30 | LDS-1518 | LINCS
Transcriptomics Breast Cancer Profiling Project, Gene Expression 1: Baseline mRNA sequencing on 35 breast cell lines
2018-07-06 | LDS-1530 | LINCS
Proteomics Breast Cancer Profiling Project - Proteomics 1: 1 total proteome dataset for a 35-cell line breast cancer panel under basal conditions
2018-10-18 | LDS-1546 | LINCS
Proteomics Breast Cancer Profiling Project - Proteomics 2: 1 phosphoproteome dataset (including phosphotyrosine enrichment) for a 35-cell line breast cancer panel under basal conditions
2018-10-18 | LDS-1547 | LINCS
Transcriptomics Single cell RNA-seq of an native and engineered metastatic niche in a metastatic breast cancer murine model
2022-08-02 | E-MTAB-8503 | biostudies-arrayexpress
Unknown Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics.
2018-08-09 | LDS-1533 | LINCS
Unknown Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values.
2018-08-09 | LDS-1532 | LINCS
Transcriptomics RHBDD2 silencing and gene expression profiling of breast cancer cells
2013-04-10 | E-GEOD-43015 | biostudies-arrayexpress
Unknown Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics
2019-06-27 | LDS-1562 | LINCS
Unknown Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values
2019-06-27 | LDS-1561 | LINCS